Elemy Valuation, Funding & Investors

Elemy is valued at $1.1B as of October 2021.

See full Elemy profile

Last Elemy valuation

$1.1B

Series B · Oct 2021

Last Elemy funding round

$219M

Series B · Oct 2021

Cumulative funding Elemy raised

$323M

across 3 funding rounds

Key investors in Elemy

Elemy Overview

About Elemy

Elemy is a provider of in-home behavioral and mental healthcare for children nationwide. Denver-headquartered, it launched autism care services in April 2020 before expanding to ADHD, OCD, anxiety, depression, social anxiety, and bipolar disorder. The platform integrates telehealth scheduling, progress tracking, and multidisciplinary teams of therapists, behavior analysts, and psychiatrists delivering whole-child treatment models. Elemy partners with insurers like UnitedHealthcare and Aetna, focusing on underserved families in 25 states with outcomes including doubled therapy adherence rates.


Founded

2019

HQ

United StatesSan Francisco, CA

Website

elemy.com

Status

Privately held

Customer focus

B2C & B2B

Revenue model

Services, Subscription

Valuation

$1.1B (Oct 2021)

Elemy Valuation

Elemy is currently valued at $1.1B, based on its Series B in October 2021.

The $219M round was led by Goodwater Capital, Premji Invest and SoftBank Group.

Elemy's valuation has moved from $1.1B at its Series A in March 2021 to $1.1B in October 2021, across 2 priced rounds.

Elemy valuation by funding round

Elemy valuation by funding round
DateStageValuation
Oct 2021Series B$1.1B
Mar 2021Series A$1.1B

Elemy Funding History

Elemy has raised a total of $323M across 3 funding rounds.

Elemy's first fundraising round was a $10M seed round in July 2020. The most recent completed round was a $219M Series B in October 2021.

Elemy funding rounds

Elemy funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Oct 2021Series BGoodwater Capital (lead); Premji Invest (lead); SoftBank Group (lead)$219M$1.1BElemy, formerly Sprout Therapy, is a San Francisco-based digital health company providing in-home and online pediatric behavioral health care for children with autism and other conditions, matching families with clinicians, behavior analysts, and therapists via telehealth to reduce wait times and use data for personalized treatment. The company raised $219 million in a Series B round around June/October 2021, led by SoftBank Vision Fund 2, co-led by Goodwater Capital and Premji Invest, with participation from Amity Ventures, Avidity Partners, Metrodora Ventures, Sound Ventures, Whale Rock Capital, and prior investors including General Catalyst, bringing total funding to $270 million. This round valued Elemy at $1.15 billion post-money, achieving unicorn status, with plans to expand staff beyond 1,000 employees, reach more states beyond the current 14, invest in R&D for technology enhancements, and enter new behavioral care areas. Elemy reported a 19x year-on-year revenue increase by end of August 2021 compared to August 2020, alongside rapid growth from 109 employees at seed to over 1,000, delivering care across 14 states, with patients showing 83% reduction in problem behaviors and 88% gain in new skills after six months.
Mar 2021Series AGeneral Catalyst (lead); Sound Ventures; SignalFire; 8VC; Felicis; Kyle Lui; ICLUB VC; Founders Fund; Bling Capital; Headline$94M$1.1BElemy, formerly known as Sprout Therapy, is an online pediatric behavioral health startup based in San Francisco that provides in-home and online care services for children with autism and other behavioral health conditions. The company pairs licensed clinicians with proprietary technology to deliver quality behavioral health treatment. Elemy was founded just over a year before its Series B round and rapidly scaled from 109 employees at seed stage to over 1,000 employees by the time of the Series B, operating in 14 states. The company raised $219 million in Series B funding led by SoftBank Vision Fund 2 and co-led by Goodwater Capital and Premji Invest, achieving a post-money valuation of $1.15 billion and reaching unicorn status. The Series B round closed on October 7, 2021, with participation from investors including Amity Ventures, Avidity Partners, Chelsea Clinton's Metrodora Ventures, Ashton Kutcher and Guy Oseary's Sound Ventures, Whale Rock Capital, and continued participation from earlier investors Bling Capital, Felicis Ventures, Founders Fund, General Catalyst, Headline, SignalFire, TABLE Management, and 8VC. The company demonstrated strong growth with a 19x year-on-year increase in revenue comparing August 2021 to August 2020. Elemy had previously raised $41 million in Series A funding in October 2020 led by General Catalyst, bringing total capital raised to $270 million as of the Series B close.
Jul 2020SeedBling Capital (lead); Felicis (lead); General Catalyst (lead); Cold Start Ventures; Charles Yu; Reshape Ventures$10M--

Who has invested in Elemy?

16 investors have backed Elemy across its funding rounds, including General Catalyst, Felicis, Bling Capital, SoftBank Group, Founders Fund and 8VC.

Lead investors include Goodwater Capital, Premji Invest, SoftBank Group, General Catalyst, Bling Capital and 1 other investor.


Elemy Investors

Investors in Elemy by funding rounds participated
InvestorHQRoundsRoleFirst check
General CatalystUnited StatesSan Francisco, CA2LeadJul 2020
FelicisUnited StatesSan Francisco, CA2LeadJul 2020
Bling CapitalUnited StatesUnited States2LeadJul 2020
Cold Start VenturesUnited StatesNew York City, NY1ParticipantJul 2020
Sound VenturesUnited StatesLos Angeles, CA1ParticipantMar 2021
SignalFireUnited StatesSan Francisco, CA1ParticipantMar 2021
SoftBank GroupJapanTokyo1LeadOct 2021
8VCUnited StatesSan Francisco, CA1ParticipantMar 2021
Charles YuUnited StatesUnited States1ParticipantJul 2020
Premji InvestIndiaBangalore1LeadOct 2021
Goodwater CapitalUnited StatesSan Francisco, CA1LeadOct 2021
Kyle LuiUnited StatesSan Francisco, CA1ParticipantMar 2021
ICLUB VCUkraineKyiv1ParticipantMar 2021

This data is available for Pro users. Sign up to see all 16 Elemy investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Elemy Competitors

Elemy competitors include listed companies like Guiyang Longmaster and Medley Inc., and private ones like Modern Health, League, Assort Health and Tala Health.

Public and private companies comparable to Elemy
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Modern HealthUnited StatesSan Francisco, CAPrivate--$1.2B-
LeagueCanadaTorontoPrivate--$1.2B-
Assort HealthUnited StatesSan Francisco, CAPrivate$3M-$1.2B-
Tala HealthUnited StatesSan Francisco, CAPrivate--$1.2B-
Guiyang LongmasterChinaChinaPublicly listed$44M$5M$482M-
Medley Inc.JapanJapanPublicly listed$236M$32M$459M1.8x

Elemy Public Comps

Elemy is still privately-owned, but its public comps include Teladoc, GoodRx, PHC Holdings, U.S. Physical Therapy, Vitec Software, iFLYHealth, EverCommerce, HealthStream, MedicalSystem Technology and Talkspace.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
PHC Holdings$2.3B$320M1.0x1.0x7.2x6.5x
U.S. Physical Therapy$781M$110M2.5x2.3x17.5x18.9x
Vitec Software$371M$151M3.7x3.5x9.1x9.0x
iFLYHealth$136M($7M)7.7x6.2x(150.8x)(144172.5x)
EverCommerce$589M$128M3.0x2.9x13.7x9.5x
HealthStream$304M$63M2.8x2.6x13.2x11.2x

This data is available for Pro users. Sign up to see all Elemy competitors and their valuation data.

Start Free Trial

Common questions about Elemy

When was Elemy founded?Elemy was founded in 2019.
Where is Elemy headquartered?Elemy is headquartered in San Francisco, CA, United States.
Is Elemy publicly listed?No, Elemy is a private, VC-backed company.
What is Elemy's valuation?Elemy was last valued at $1.1B in its Series B in October 2021.
How much funding has Elemy raised?Elemy has raised $323M across 3 funding rounds.
What was Elemy's last funding round?Elemy's last funding round was a $219M Series B in October 2021, led by Goodwater Capital, Premji Invest and SoftBank Group.
Who are Elemy's investors?Elemy's investors include General Catalyst, Felicis, Bling Capital, Cold Start Ventures, Sound Ventures, SignalFire, SoftBank Group, 8VC, Charles Yu, Premji Invest and 6 others.
Which companies are comparable to Elemy?Companies comparable to Elemy include Modern Health, League, Assort Health, Tala Health, Guiyang Longmaster and Medley Inc..

See companies similar to Elemy

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial